ATE206042T1 - Verfahren zur herstellung von niedrigdosierten arzneimitteln - Google Patents

Verfahren zur herstellung von niedrigdosierten arzneimitteln

Info

Publication number
ATE206042T1
ATE206042T1 AT95906665T AT95906665T ATE206042T1 AT E206042 T1 ATE206042 T1 AT E206042T1 AT 95906665 T AT95906665 T AT 95906665T AT 95906665 T AT95906665 T AT 95906665T AT E206042 T1 ATE206042 T1 AT E206042T1
Authority
AT
Austria
Prior art keywords
low dose
medicinal products
producing low
dose medicinal
low
Prior art date
Application number
AT95906665T
Other languages
English (en)
Inventor
Frank C Greaves
James Swarbrick
Martin W Beasley
Andrew W Suddith
Henry C Caldwell
Original Assignee
Endeavor Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25583539&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE206042(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Endeavor Pharmaceuticals filed Critical Endeavor Pharmaceuticals
Application granted granted Critical
Publication of ATE206042T1 publication Critical patent/ATE206042T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
AT95906665T 1993-12-21 1994-12-20 Verfahren zur herstellung von niedrigdosierten arzneimitteln ATE206042T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ZA939565A ZA939565B (en) 1993-12-21 1993-12-21 Method for preparing low dose pharmaceutical products.
PCT/US1994/014638 WO1995017168A1 (en) 1993-12-21 1994-12-20 Method for preparing low dose pharmaceutical products

Publications (1)

Publication Number Publication Date
ATE206042T1 true ATE206042T1 (de) 2001-10-15

Family

ID=25583539

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95906665T ATE206042T1 (de) 1993-12-21 1994-12-20 Verfahren zur herstellung von niedrigdosierten arzneimitteln

Country Status (6)

Country Link
EP (1) EP0735864B2 (de)
AT (1) ATE206042T1 (de)
AU (1) AU1515595A (de)
DE (1) DE69428455T3 (de)
WO (1) WO1995017168A1 (de)
ZA (1) ZA939565B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0782449T3 (da) * 1994-09-22 2003-08-04 Akzo Nobel Nv Fremgangsmåde til fremstilling af doseringsenheder ved vådgranulering
US5759577A (en) * 1995-01-17 1998-06-02 American Home Products Corporation Controlled release of steroids from sugar coatings
AR004178A1 (es) * 1995-07-29 1998-11-04 Smithkline Beecham Plc Procedimiento para la formulacion de un farmaco, una composicion farmaceutica obtenible mediante este procedimiento y el uso de la misma.
AU2461999A (en) * 1998-01-16 1999-08-02 Davitz, Michael A. Pharmaceutical composition and method for treating di-hydroxytestosterone dependent conditions
JP4868695B2 (ja) * 2000-09-22 2012-02-01 大日本住友製薬株式会社 崩壊性が良好な経口製剤
US8530509B2 (en) 2003-06-20 2013-09-10 Siga Technologies, Inc. Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases
EP1734930A2 (de) * 2004-04-09 2006-12-27 Smithkline Beecham Corporation Niedrig dosierte pharmazeutische präparate
UY29527A1 (es) * 2005-05-13 2006-12-29 Schering Ag Composicinn farmaccutica que contienen gestrgenos y/o estrngenos y 5-metil - (6s) - tetrhidrofolato.
US8617597B2 (en) 2006-07-06 2013-12-31 Bayer Intellectual Property Gmbh Pharmaceutical composition containing a tetrahydrofolic acid
US8512745B2 (en) 2008-12-08 2013-08-20 Laboratoire Hra Pharma Ulipristal acetate tablets
KR20130018271A (ko) 2010-03-23 2013-02-20 시가 테크놀로지스, 인크. 다형체 형태 ｓｔ―２４６ 및 제조방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2146239A1 (de) † 1970-09-25 1972-03-30 CIBA Geigy AG, Basel (Schweiz) Neue antikonzeptionelle Mittel
DE2310963A1 (de) † 1972-04-14 1974-09-05 Schering Ag Methode zur kontrazeption durch verabfolgung von stufenkombinationspraeparaten
US3969502A (en) † 1972-04-14 1976-07-13 Schering Aktiengesellschaft Method for contraception by the administration of sequential contraceptive preparations
SE457326B (sv) † 1986-02-14 1988-12-19 Lejus Medical Ab Foerfarande foer framstaellning av en snabbt soenderfallande kaerna innehaallande bl a mikrokristallin cellulosa
US5073374A (en) * 1988-11-30 1991-12-17 Schering Corporation Fast dissolving buccal tablet
IE67345B1 (en) * 1991-03-12 1996-03-20 Akzo Nv Low dose dry pharmaceutical preparations

Also Published As

Publication number Publication date
ZA939565B (en) 1994-08-11
DE69428455D1 (de) 2001-10-31
JPH09506899A (ja) 1997-07-08
EP0735864B2 (de) 2004-09-01
JP3883204B2 (ja) 2007-02-21
AU1515595A (en) 1995-07-10
EP0735864B1 (de) 2001-09-26
WO1995017168A1 (en) 1995-06-29
DE69428455T3 (de) 2005-01-20
DE69428455T2 (de) 2002-05-29
EP0735864A1 (de) 1996-10-09

Similar Documents

Publication Publication Date Title
DE58906926D1 (de) Neue Arzneimittelformulierung sowie Verfahren zu deren Herstellung.
DE3872739D1 (de) Arzneimittel mit langsamer freisetzung.
DE3678661D1 (de) Arzneimittel mit langsamer wirkstofffreisetzung.
NO175240C (no) Fremgangsmåte for fremstilling av et langsomt frigivende farmasöytisk preparat som omfatter sekundære granuler
EP0875245A3 (de) Polymermischung enthaltende Matrix mit verzögerter Wirkstoffabgabe für pharmazeutische Verwendungen
IS1694B (is) Lyfjablanda til að gefa dýrum um munn sem inniheldur prótonupumpublokkara
HUT57202A (en) Process for producing new pharmaceutically active 5-fluoro-2-///4-/cyclopropyl-methoxy/-2-pyridinyl/-methyl-sulfonyl/-1h-benzimidazol and pharmaceutical compositions containing them
AU1211992A (en) Low dose dry pharmaceutical preparations
WO2001041770A3 (en) Nanoparticulate eplerenone compositions
YU31599A (sh) Brzo oslobadjajući i za ukus maskirajući farmaceutski oblik doze
BR0003158A (pt) Formulação de dosagem oral de derretimentoinstantâneo
HUT55403A (en) Process for producing modified gangliosides and their functional derivatives, as well as pharmaceutical compositions comprising such active ingredient
DE69428455D1 (de) Verfahren zur herstellung von niedrigdosierten arzneimitteln
AU566228B2 (en) Compressed hydroxybutryic acid polymer retarded release vehicle
ATE169818T1 (de) Carbamazepin-arzneiform mit verzögerter wirkstofffreisetzung
KR860006265A (ko) 9,10-디하이드로 에르고트 알카로이드를 함유하는 서방성 제재의 제조방법
CA2176461A1 (en) Method for preparing low dose pharmaceutical products
UA66925C2 (uk) Поліморфні форми кристалічного цитрату азабіцикло[2.2.2]-октан-3-аміну, спосіб їх одержання, фармацевтична композиція та спосіб лікування блювання
DE69103724D1 (de) Pharmazeutische zusammensetzungen mit verzögerter freisetzung zur oralen verabreichung sowie deren herstellungsverfahren.
ATE212840T1 (de) Oral anzuwendende feste arzneizubereitungen mit modulierter wirkstoffabgabe enthaltend nicorandil und verfahren zu deren herstellung
AU6037494A (en) Use of active substances in the therapy of certain diseases, process for preparing a pharmaceutical composition for that purpose and pharmaceutical compositions thus prepared
EP0347531A3 (de) Verwendung von 1,3-Dithiol-2-Thion-Derivate bei der Behandlung von Lebererkrankungen
NO964775L (no) Fast farmasöytisk adenosinholdig preparat
BR0008065A (pt) Derivados de colestano insaturados e seu uso para a preparação de medicamentos que regulam meiose
IL122719A (en) Controlled release pharmaceutical dosage forms for oral administration containing nifedipine as active substance and process for their preparation

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties